Researchers found that by limiting asparagine in laboratory mice with triple-negative breast cancer, they could dramatically reduce the ability of the cancer to travel to distant sites in the body.
In the study, published in the journal Nature, the team used dietary restrictions to limit asparagine among other techniques.
Foods rich in asparagine include dairy, whey, beef, poultry, eggs, fish, seafood, asparagus, potatoes, legumes, nuts, seeds, soy and whole grains. Foods low in asparagine include most fruits and vegetables.
If further research confirms the findings in human cells, limiting the amount of asparagine cancer patients ingest could be a potential strategy to augment existing therapies and to prevent the spread of breast cancer, Knott added.
"This study may have implications not only for breast cancer, but for many metastatic cancers," said Ravi Thadhani, vice dean, Research and Graduate Research Education, at Cedars-Sinai.
The researchers studied triple-negative breast cancer cells, which grow and spread faster than most other types of cancer cells.
As a result, it resists common treatments - which target these factors and has a higher-than-average mortality rate.
The researchers discovered that the appearance of asparagine synthetase - the enzyme cells used to make asparagine - in a primary tumor was strongly associated with later cancer spread.
They also found that metastasis was greatly limited by reducing asparagine synthetase, treatment with the chemotherapy drug L-asparaginase, or dietary restriction.
When the lab mice were given food rich in asparagine, the cancer cells spread more rapidly.
Investigators now are considering conducting an early- phase clinical trial in which healthy participants would consume a low-asparagine diet.
If the diet results in decreased levels of asparagine, the next scientific step would involve a clinical trial with cancer patients.
That trial likely would employ dietary restrictions as well as chemotherapy and immunotherapy, Knott said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
